Back to Search Start Over

Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats.: LPC aggravates liver CCl4-induced fibrosis

Authors :
Agnès Fourcot
Y. Laperche
Arthur Brouillet
Marie-Noële Chobert
Dominique Couchie
P. Mavier
Elie-Serge Zafrani
Institut Mondor de Recherche Biomédicale (IMRB)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10
Université Paris-Est Marne-la-Vallée (UPEM)
Département de pathologie [Mondor]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
This work was supported by INSERM, University Paris-Est Creteil and Agence Nationale pour la Recherche (ANR-06-Physio-022-2).
Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Source :
Laboratory Investigation, Laboratory Investigation, Nature Publishing Group, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩, Laboratory Investigation, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩
Publication Year :
2012
Publisher :
HAL CCSD, 2012.

Abstract

International audience; Hepatic fibrosis, the major complication of virtually all types of chronic liver damage, usually begins in portal areas, and its severity has been correlated to liver progenitor cells (LPC) expansion from periportal areas, even if the primary targets of injury are intralobular hepatocytes. The aim of this study was to determine the potential fibrogenic role of LPC, using a new experimental model in which rat liver fibrosis was induced by chronic carbon tetrachloride (CCl(4)) administration for 6 weeks, in combination with chronic acetylaminofluorene treatment (AAF), which promotes activation of LPC compartment. Treatment with CCl(4) alone caused a significant increase in serum transaminase activity as well as liver fibrosis initiating around central veins and leading to formation of incomplete centro-central septa with sparse fibrogenic cells expressing α-smooth muscle actin (αSMA). In AAF/CCl(4)-treated animals, the fibrogenic response was profoundly worsened, with formation of multiple porto-central bridging septa leading to cirrhosis, whereas hepatocellular necrosis and inflammation were similar to those observed in CCl(4)-treated animals. Enhanced fibrosis in AAF/CCl(4) group was accompanied by ductule forming LPC expanding from portal areas, αSMA-positive cells accumulation in the fibrotic areas and increased expression of hepatic collagen type 1, 3 and 4 mRNA. Moreover, CK19-positive LPC expressed the most potent fibrogenic cytokine transforming growth factor-β (TGFβ) without any expression of αSMA, desmin or fibroblast-specific protein-1, demonstrating that LPC did not undergo an epithelial-mesenchymal transition. In this new experimental model, LPC, by expressing TGFβ, contributed to the accumulation of αSMA-positive myofibroblasts in the ductular reaction leading to enhanced fibrosis but also to disease progression and to a fibrotic pattern similar to that observed in humans.

Details

Language :
English
ISSN :
00236837 and 15300307
Database :
OpenAIRE
Journal :
Laboratory Investigation, Laboratory Investigation, Nature Publishing Group, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩, Laboratory Investigation, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩
Accession number :
edsair.doi.dedup.....bcf54c1eb7cb77bba688c4a3db6ce7a5
Full Text :
https://doi.org/10.1038/labinvest.2011.143⟩